TLR4 and Hepatic fibrosis: Quiescent HSCs highly express BAMBI (bone morphogenetic protein and activin membrane bound inhibitor), but their transcriptional activity is inhibited after LPS treatment, which contributes to TLR4-mediated enhancement of transforming growth factor (TGF)-β signalling in HSCs during liver fibrosis (Liu et al., 2014).